CryoPort Inc (CYRX)

[laser777]

Nice, but long article on the importance of logistics in the commercialization of cell based biologics. I had to read it twice for it to sink in. Sheds new light on the challenges that arise in the manufacture and delivery of these new therapies.

Because autologous therapies are comprised of living cells with a limited lifespan, logistics expertise will be incredibly important to coordinate and connect services that are designed as a unique program - tailored to perfectly sync with the apheresis center, provider, manufacturer and patient for each cell therapy. Some of the many services that a manufacturer may require include: the fulfillment of kitting at apheresis site, the coordination and tracking of shipments, temperature monitoring and real-time temperature tracking, notification of interruptions or changes, chain of custody tracking, product data monitoring, and advanced cryopreservation and cryoshipping technologies that add an element of flexibility in the supply chain. Manufacturers should also ask logistics partners about their experience with contingency planning to assess their capability to resolving a variety of unexpected situations.

https://www.dddmag.com/article/2017/06/new-challenges-redefine-complexity-commercialization